Avacta Group (AVCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Mar 2024 04:00 PM
RNS
Investor Webinar
21 Mar 2024 07:00 AM
RNS
Update on AVA6000 Phase 1a Clinical Trial Progress
18 Mar 2024 01:26 PM
RNS
Result of General Meeting
06 Mar 2024 07:00 AM
RNS
Avacta Announces AVA6000 Poster at AACR
05 Mar 2024 07:00 AM
RNS
Result of REX Retail Offer
29 Feb 2024 07:00 AM
RNS
Result of Placing
28 Feb 2024 04:42 PM
RNS
Proposed REX Retail Offer
28 Feb 2024 04:41 PM
RNS
Proposed Fundraise to progress Therapeutics
16 Feb 2024 07:00 AM
RNS
Share Incentive Plan/Issue of Equity
22 Jan 2024 10:51 AM
RNS
Issue of Equity and Total Voting Rights
19 Jan 2024 07:00 AM
RNS
Appointment of Christina Coughlin
19 Dec 2023 07:00 AM
RNS
Appointment of Chief Business Officer
13 Dec 2023 07:00 AM
RNS
ALS-6000-101 Phase 1a Study Data
04 Dec 2023 07:00 AM
RNS
Shareholder update to review AVA6000 Phase 1a data
27 Oct 2023 07:00 AM
RNS
Block Listing Six Monthly Return
23 Oct 2023 01:30 PM
RNS
Issue of Equity and Total Voting Rights
18 Oct 2023 01:00 PM
RNS
Block Listing Application to AIM
05 Oct 2023 07:00 AM
RNS
Avacta to present at AACR-NCI-EORTC conference
29 Sep 2023 01:30 PM
RNS
Director/PDMR Shareholding
28 Sep 2023 07:00 AM
RNS
Interim Results for the Period Ending 30 June 2023
20 Sep 2023 02:00 PM
RNS
Issue of Equity and Total Voting Rights
20 Sep 2023 07:01 AM
RNS
Peel Hunt Appointed as Joint Broker
20 Sep 2023 07:00 AM
RNS
Appointment Dr.Christina Coughlin as a consultant
19 Sep 2023 07:00 AM
RNS
Successful Completion of Sixth Dose Escalation
06 Sep 2023 07:00 AM
RNS
Notice of Results
21 Jul 2023 03:00 PM
RNS
Issue of Equity and Total Voting Rights
28 Jun 2023 11:00 AM
RNS
Result of Annual General Meeting
28 Jun 2023 07:00 AM
RNS
Annual General Meeting and Shareholder Event
21 Jun 2023 07:00 AM
RNS
Completion of Fifth Dose Escalation in AVA6000
19 Jun 2023 07:01 AM
RNS
Director Appointment
19 Jun 2023 07:00 AM
RNS
Statement regarding market speculation
08 Jun 2023 07:00 AM
RNS
AGM and Shareholder Event Detailed Agenda
05 Jun 2023 07:00 AM
RNS
Second Milestone in AffyXell Joint Venture
02 Jun 2023 07:00 AM
RNS
Posting of Annual Report and Notice of AGM
01 Jun 2023 07:00 AM
RNS
Avacta acquires Coris Bioconcept
27 Apr 2023 07:00 AM
RNS
Block Listing Six Monthly Return
27 Apr 2023 07:00 AM
RNS
First Patient Dosed in the US in AVA6000 Phase 1
25 Apr 2023 07:00 AM
RNS
Preliminary Results
25 Apr 2023 07:00 AM
RNS
Preliminary Results
21 Apr 2023 02:49 PM
RNS
Issue of Equity and Total Voting Rights
21 Apr 2023 02:49 PM
RNS
Issue of Equity and Total Voting Rights
17 Apr 2023 07:00 AM
RNS
AVA3996 data poster presented at AACR
06 Apr 2023 07:00 AM
RNS
1st US Clinical Investigator AVA6000 Sites Opened
05 Apr 2023 07:00 AM
RNS
First Patient Dosed in Fifth Cohort of AVA6000
03 Apr 2023 07:00 AM
RNS
Notice of Results and Investor Presentation
27 Mar 2023 07:00 AM
RNS
AVA3996 data poster presentation at AACR
13 Mar 2023 07:00 AM
RNS
Statement re: Silicon Valley Bank
23 Feb 2023 07:00 AM
RNS
Avacta Therapeutics Division Science Day
13 Feb 2023 07:00 AM
RNS
Issue of Equity and Total Voting Rights
23 Jan 2023 12:20 PM
RNS
Issue of Equity and Total Voting Rights
UK 100